These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 15929273)

  • 1. [Cardiac arrest following treatment with non-cardiologic QT-interval-increasing medications].
    Al-Amood S; Elming H
    Ugeskr Laeger; 2005 May; 167(18):1966-8. PubMed ID: 15929273
    [No Abstract]   [Full Text] [Related]  

  • 2. What has the patient been taking?
    Pasco J
    Aust Fam Physician; 1998 Jun; 27(6):517. PubMed ID: 9648320
    [No Abstract]   [Full Text] [Related]  

  • 3. Assessing the cardiac safety of ebastine. Prologue.
    Roberts DJ
    Drug Saf; 1999; 21 Suppl 1():1-3. PubMed ID: 10597862
    [No Abstract]   [Full Text] [Related]  

  • 4. [Side effects, unwanted drug interactions and the problem of cardiotoxicity].
    Woroń J; Trabka-Janik E; Kostka-Trabka E
    Przegl Lek; 2003; 60(4):196-8. PubMed ID: 14569882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The proarrhythmogenic activity of non-anti-arrhythmia drugs. Is treatment with antihistamines and cisapride safe?].
    Pelov R; Tankova L; Krushkov I
    Vutr Boles; 1999; 31(2-3):5-9. PubMed ID: 10847134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An unusual cause of cardiac arrest].
    Campana A; Manzo M; Brigante M; Marrazzo N; Melchiorre G
    Ital Heart J Suppl; 2003 Jun; 4(6):510-3. PubMed ID: 19400057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. QT interval prolongation and torsade de pointes associated with indapamide.
    Letsas KP; Alexanian IP; Pappas LK; Kounas SP; Efremidis M; Sideris A; Kardaras F
    Int J Cardiol; 2006 Oct; 112(3):373-4. PubMed ID: 16260053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cisapride-induced torsades de pointes.
    Vitola J; Vukanovic J; Roden DM
    J Cardiovasc Electrophysiol; 1998 Oct; 9(10):1109-13. PubMed ID: 9817562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
    Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
    Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diuretic-induced potassium and magnesium deficiency: relation to drug-induced QT prolongation, cardiac arrhythmias and sudden death.
    Singh BN; Hollenberg NK; Poole-Wilson PA; Robertson JI
    J Hypertens; 1992 Apr; 10(4):301-16. PubMed ID: 1316396
    [No Abstract]   [Full Text] [Related]  

  • 11. Terfenadine should be withdrawn from clinical use.
    Khilnani G
    J Assoc Physicians India; 1999 Sep; 47(9):943. PubMed ID: 10778682
    [No Abstract]   [Full Text] [Related]  

  • 12. Torsades de pointes in two chronic renal failure patients treated with cisapride and clarithromycin.
    Sekkarie MA
    Am J Kidney Dis; 1997 Sep; 30(3):437-9. PubMed ID: 9292575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Torsades de pointes during low-dosage sotalol therapy in haemodialysis patients.
    Huynh-Do U; Wahl C; Sulzer M; Bühler H; Keusch G
    Nephrol Dial Transplant; 1996 Jun; 11(6):1153-4. PubMed ID: 8671988
    [No Abstract]   [Full Text] [Related]  

  • 14. Diuretic therapy and the risk of cardiac arrest.
    Moser M; Gifford R
    N Engl J Med; 1994 Nov; 331(18):1235-6. PubMed ID: 7935674
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug-induced cardiac arrhythmias: incidence, prevention and management.
    Doig JC
    Drug Saf; 1997 Oct; 17(4):265-75. PubMed ID: 9352962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiotoxicity of new antihistamines and cisapride.
    Paakkari I
    Toxicol Lett; 2002 Feb; 127(1-3):279-84. PubMed ID: 12052668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some observations on the cardiotoxic and drug interaction profiles of second generation antihistamines as measured in the guinea pig.
    Roberts DJ; Llenas J
    Arzneimittelforschung; 1996 Aug; 46(8):832-3. PubMed ID: 9125289
    [No Abstract]   [Full Text] [Related]  

  • 18. Long QT syndrome during high-dose cisapride.
    Bran S; Murray WA; Hirsch IB; Palmer JP
    Arch Intern Med; 1995 Apr; 155(7):765-8. PubMed ID: 7695465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sotalol, hypokalemia and torsade de pointes ventricular tachycardia].
    Rudnicki PM; Lauritsen H; Petersen HH
    Ugeskr Laeger; 1986 Sep; 148(36):2294-5. PubMed ID: 3775913
    [No Abstract]   [Full Text] [Related]  

  • 20. Terfenadine, astemizole, and ebastine produce QTc interval prolongation in an experimental model predictive of adverse clinical ECG effects.
    Hey JA; del Prado M; Egan RW; Kreutner W
    Ann Allergy Asthma Immunol; 1996 May; 76(5):476. PubMed ID: 8630724
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.